Back to news archive
Image for Successful pre-clinical testing of QuickMIC® in the US
News 2024-01-19

Successful pre-clinical testing of QuickMIC® in the US

Today we announce the successful completion of our pre-clinical testing of the QuickMIC® system in the US. The evaluation of our QuickMIC® system showed excellent performance and holds promises for the upcoming FDA study. Results from the US pre-clinical study will be presented at significant microbiology conferences during the next year.

This pre-clinical testing included about a hundred clinical patient samples and was performed at two reputable US clinical laboratories.

To press release

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book